Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects of Trehalose on Bone Healing, Physical Function, and Pain in Patients With Pertrochanteric Fractures: A Randomized Controlled Trial Protocol Publisher Pubmed



Zandi R1, 9 ; Razani HO2 ; Mehrvar A1 ; Jowshan MR3 ; Sahebkar A4, 5, 10 ; Nikooyeh B6 ; Zahedi H7, 8 ; Talebi S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Orthopedics, School of Medicine, Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Student Research Committee, Department of Orthopedics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Department of Nutrition Research, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  9. 9. Musculoskeletal Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  10. 10. Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India

Source: Trials Published:2024


Abstract

Background: Appropriate management of fractures is crucial for restoring natural bone function and preventing long-term complications. Previous research on animal models indicates that trehalose can improve bone fracture healing by inhibiting the inflammatory cascade. We hope that trehalose can accelerate bone fracture healing in humans, alleviate pain, and ultimately enhance the individual’s quality of life. Methods: This randomized, double-blind clinical trial will be conducted at Taleghani Hospital in Tehran, Iran. Sixty-four patients admitted to the orthopedic ward will be enrolled based on eligibility criteria. The participants will be randomly allocated based on the permuted block randomization into two groups: those receiving trehalose (32 patients) or placebo (32 patients). The patients in the trehalose and placebo groups will receive 3.3 g of trehalose or placebo for 12 weeks, respectively. A consent form, general questionnaire, as well as the Visual Analog Scale (VAS), Harris Hip Score (HHS), and radiological analyses will be used to assess fracture healing quality. The intention-to-treat principle will form the basis of the statistical analysis. Discussion: The trial results may provide a convenient and safe adjuvant treatment option for the Pertrochanteric Fractures population. Trial registration: Iranian Registry of Clinical Trials. IRCT20240605062013N1. URL of the trial registry record: https://irct.behdasht.gov.ir/trial/77212. Registration date: 16 June 2024. © The Author(s) 2024.